Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2008

01-02-2008 | Bone and Soft Tissue Sarcomas

Practice Pearl: A Novel use of Botulinum toxin for Unicameral Bone Cyst Ablation

Author: Hamid Namazi, MD

Published in: Annals of Surgical Oncology | Issue 2/2008

Login to get access

Excerpt

A major challenge in contemporary medicine is to break the traditional compartmentalization that frequently separates various fields. Unexpected linkages between various areas of medicine are indeed of particular interest. …
Literature
1.
Brecelj J, Suhodolcans L. Continuous decompression of unicameral bone cyst with cannulated screws: a comparative study. J Pediatr Orthop B 2007; 16(5):367–72PubMed
2.
Givon U. Percutaneous reaming of simple bone cysts in children followed by injection of demineralized bone matrix and autologous bone marrow. J Pediatr Orthop 2007; 27(3):363PubMed
3.
Vasconcellos DA, Yandow SM, Grace AM, et al. Cyst index: a nonpredictor of simple bone cyst fracture. J Pediatr Orthop 2007; 27(3): 307–10PubMed
4.
Allende-vigo MZ. The use of biochemical markers of bone turnover in osteoporosis. P R Health Sci J 2007; 26(2):91–5PubMed
5.
Beyens G, Van Hul W. Pathophysiology and genetics of metabolic bone disorders characterized by increased bone turnover. Crit Rev Eukaryot Gene Expr 2007; 17(3):215–40PubMed
6.
Pavalko FM, Chen NX, Turner CH, et al. Fluid shear-induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions. Am J Physiol 1998; 275:1591–601
7.
Han SY, Lee NK, Kim KH, et al. Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis. Blood 2005 15; 106(4):1240–5
8.
Denoyelle C, Hong L, Vannier JP, et al. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. Br J Cancer 2003; 88(10):1631–40PubMedCrossRef
9.
Azim AC, Cao H, Gao X, et al. Regulation of cyclooxygenase-2 expression by small GTPase Rac2 in bone marrow macrophages. Am J Physiol Lung Cell Mol Physiol 2007; 293(3):668–73CrossRef
10.
Coon D, Gulati A, Cowan C, et al. The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption. J Endod 2007; 33(4):432–6PubMedCrossRef
11.
Liu XH, Kirschenbaum A, Yao S, et al. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann N Y Acad Sci 2006;1068:225–33PubMedCrossRef
12.
Ha H, Lee JH, Kim HN, et al. Alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol 2006; 176(1):111–7PubMed
13.
Razga F, Koca J, Mokdad A, et al. Elastic properties of ribosomal RNA building blocks: molecular dynamics of the GTPase-associated center rRNA. Nucleic Acids Res 2007; 35(12):4007–17PubMedCrossRef
14.
Gras S, Chaumont V, Fernandez B, et al. Structural insights into a new homodimeric self-activated GTPase family. EMBO Rep 2007; 8(6):569–75PubMedCrossRef
15.
Holbourn KP, Sutton JM, Shore C, et al. Molecular recognition of an ADP-ribosyl transferase; clostridium botulinum C3 exoenzyme. Proc Natl Acad Sci 2005;102:535–5364CrossRef
16.
Harmey D, Stenbeck G, Nobes CD, et al. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res 2004; 4:661–7CrossRef
17.
Singh R, Wang B, Shirraikar A, et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 1999; 11:1561–70
18.
Wilde C, Genth H, Aktories K, et al. Recognition of RhoA by Clostridium botulinum C3 exoenzyme. J Biol Chem 2000; 275(22):16478–83PubMedCrossRef
19.
Bacon KB, Schall TJ, Dairaghi DJ. RANTES activation of phospholipase D in Jurkat T cells: requirement of GTP-binding proteins ARF and RhoA. J Immunol 1998; 160(4):1894–900PubMed
20.
Mazur P, Baginsky W. In vitro activity of 1, 3-beta-D-glucan synthase requires the GTP-binding protein Rho1. J Biol Chem 1996; 271(24):14604–9PubMedCrossRef
Metadata
Title
Practice Pearl: A Novel use of Botulinum toxin for Unicameral Bone Cyst Ablation
Author
Hamid Namazi, MD
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9644-9

Other articles of this Issue 2/2008

Annals of Surgical Oncology 2/2008 Go to the issue

Gastrointestinal Oncology

Concurrent Chemoradiotherapy or Endoscopic Stenting for Advanced Squamous Cell Carcinoma of Esophagus: A Case-Control Study

Gastrointestinal Oncology

Effect of Adjuvant Radiotherapy on Local Recurrence in Stage II Rectal Cancer

Hepatic and Pancreatic Tumors

Prognostic Factors and Optimal Treatment Strategy for Intrahepatic Nodular Recurrence After Curative Resection of Hepatocellular Carcinoma

Gastrointestinal Oncology

Impact of the Site of Anastomosis after Oncologic Esophagectomy on Quality of Life — A Prospective, Longitudinal Outcome Study

Gastrointestinal Oncology

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Gastrointestinal Oncology

Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer